Infrequent COX-2 expression due to promoter hypermethylation in gastric cancers in Dalian, China

Plummer, 2004, Epidemiology of gastric cancer, IARC Sci Publ, 157, 311 Mervis, 1995, China's unique environment favors large intervention trials, Science, 270, 1149, 10.1126/science.270.5239.1149 DeWitt, 1991, Prostaglandin endoperoxide synthase: regulation of enzyme expression, Biochim Biophys Acta, 1083, 121, 10.1016/0005-2760(91)90032-D Smith, 1996, Prostaglandin endoperoxide H synthases (cyclooxygenases)–1 and –2, J Biol Chem, 271, 33157, 10.1074/jbc.271.17.9906 Soumaoro, 2004, Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer, Clin Cancer Res, 10, 8465, 10.1158/1078-0432.CCR-04-0653 Fujita, 2002, Cyclooxygenase-2 promotes prostate cancer progression, Prostate, 53, 232, 10.1002/pros.10152 Yuan, 2005, Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non–small cell lung cancer patients, Int J Cancer, 115, 545, 10.1002/ijc.20898 Franco, 2004, Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer, Prostaglandins Other Lipid Mediat, 73, 51, 10.1016/j.prostaglandins.2003.12.001 Lee, 2004, Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines, Head Neck, 26, 706, 10.1002/hed.20025 Tatsuguchi, 2004, Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue, Hum Pathol, 35, 488, 10.1016/j.humpath.2003.10.025 Yamagishi, 2004, Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer, J Gastroenterol, 39, 1143, 10.1007/s00535-004-1463-1 Huang, 2005, Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma, J Biomed Sci, 12, 229, 10.1007/s11373-004-8177-5 Buecher, 2005, Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines, Anticancer Res, 25, 225 Basu, 2004, Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer, Mol Cancer Res, 2, 632, 10.1158/1541-7786.632.2.11 Liao, 2004, COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer, Expert Rev Anticancer Ther, 4, 543, 10.1586/14737140.4.4.543 Juttner, 2003, Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors, Cell Microbiol, 5, 821, 10.1046/j.1462-5822.2003.00324.x Yang, 2005, Loss of TNF-alpha–regulated COX-2 expression in ovarian cancer cells, Oncogene, 24, 7991, 10.1038/sj.onc.1208943 Hung, 2004, Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase, J Biol Chem, 279, 46384, 10.1074/jbc.M403568200 Howe, 1999, Transcriptional activation of cyclooxygenase-2 in Wnt-1–transformed mouse mammary epithelial cells, Cancer Res, 59, 1572 Wang, 2003, Meta-analysis on the epidemiology of Helicobacter pylori infection in China, Chin J Epidemiol, 24, 443 Parsonnet, 1991, Helicobacter pylori infection and the risk of gastric carcinoma, N Engl J Med, 325, 1127, 10.1056/NEJM199110173251603 Nomura, 1991, Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii, N Engl J Med, 325, 1132, 10.1056/NEJM199110173251604 Forman, 1991, Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation, BMJ, 302, 1302, 10.1136/bmj.302.6788.1302 Nardone, 2004, Expression of COX-2, mPGE-synthase 1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori–related gastric arcinogenesis, J Pathol, 202, 305, 10.1002/path.1512 Wambura, 2002, Effect of Helicobacter pylori–induced cyclooxygenase-2 on gastric epithelial cell kinetics: implication for gastric carcinogenesis, Helicobacter, 7, 129, 10.1046/j.1083-4389.2002.00069.x Chang, 2004, Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src–dependent nuclear factor-kappaB activation, Mol Pharmacol, 66, 1465, 10.1124/mol.104.005199 Suganuma, 2006, Carcinogenic role of tumor necrosis factor-α inducing protein of Helicobacter pylori in human stomach, J Biochem Mol Biol, 39, 1, 10.5483/BMBRep.2006.39.1.001 Sasaki, 2001, Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue, Clin Cancer Res, 7, 4136 Araki, 2003, Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways, Cancer Res, 63, 728 Katoh, 2001, Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer, Int J Oncol, 19, 1003 Cheng, 2005, Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination, Cancer Lett, 223, 339, 10.1016/j.canlet.2004.11.013 Li, 2003, Combination of nucleic acid and protein isolation with tissue array construction: using defined histologic regions in single frozen tissue blocks for multiple research purposes, Int J Mol Med, 12, 299 Lee, 2003, Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis, Am J Pathol, 163, 1371, 10.1016/S0002-9440(10)63495-5 Mohan, 2000, Modulation of TNF-alpha–induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB, Invest Ophthalmol Vis Sci, 41, 1327 Fang, 2001, Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation, J Virol, 75, 9753, 10.1128/JVI.75.20.9753-9761.2001 Robertson, 1999, The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissue and overexpression in tumors, Nucleic Acids Res, 27, 2291, 10.1093/nar/27.11.2291 Uemura, 2001, Helicobacter pylori infection and the development of gastric cancer, N Engl J Med, 345, 784, 10.1056/NEJMoa001999 Murata, 2004, Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells, Lab Invest, 84, 1050, 10.1038/labinvest.3700118 Milas, 2003, Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non–small cell lung cancer and brain metastases, Clin Cancer Res, 9, 1070 McGeehan, 1994, Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor, Nature, 370, 558, 10.1038/370558a0 Han, 2003, Expression of COX-2 in stomach cancers and its relation to their biological features, Dig Surg, 20, 107, 10.1159/000069384 Lim, 2000, Increased expression of cyclooxygenase-2 protein in human gastric carcinoma, Clin Cancer Res, 6, 519 FitzGerald, 2003, COX-2 and beyond: approaches to prostaglandin inhibition in human disease, Nat Rev Drug Discov, 2, 879, 10.1038/nrd1225 Sung, 2000, Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions, Am J Pathol, 157, 729, 10.1016/S0002-9440(10)64586-5 Sharma, 1998, Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells, J Immunol, 160, 2401, 10.4049/jimmunol.160.5.2401 Noach, 1994, Mucosal tumor necrosis factor-α interleukin-1β and interleukin-8 production in patients with Helicobacter pylori infection, Scand J Gastroenterol, 29, 425, 10.3109/00365529409096833 Maeda, 2001, Distinct mechanism of Helicobacter pylori–mediated NF-kappa B activation between gastric cancer cells and monocytic cells, J Biol Chem, 276, 44856, 10.1074/jbc.M105381200 Watanabe, 2000, Helicobacter pylori induces apoptosis in gastric epithelial cells through inducible nitric oxide, J Gastroenterol Hepatol, 15, 168, 10.1046/j.1440-1746.2000.02062.x Konturek, 2004, Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis: link to Helicobacter pylori–infection, J Pharmacol Sci, 96, 134, 10.1254/jphs.FPJ04016X Naumann, 2001, Host cell signaling in Helicobacter pylori infection, Int J Med Microbiol, 291, 299, 10.1078/1438-4221-00133 Covacci, 1999, Helicobacter pylori virulence and genetic geography, Science, 284, 1328, 10.1126/science.284.5418.1328 Yamaoka, 1999, Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries, J Clin Microbiol, 37, 2274, 10.1128/JCM.37.7.2274-2279.1999 Aggarwal, 2003, Signalling pathways of the TNF superfamily: a double-edged sword, Nat Rev Immunol, 3, 745, 10.1038/nri1184 Kim, 2003, Helicobacter pylori infection activates NF-kappaB signaling pathway to induce iNOS and protect human gastric epithelial cells from apoptosis, Am J Physiol Gastrointest Liver Physiol, 285, 1171, 10.1152/ajpgi.00502.2002 Inoue, 1998, Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells, Biochem Biophys Res Commun, 244, 143, 10.1006/bbrc.1998.8222 Nelson, 2004, Convergence of Wnt, beta-catenin, and cadherin pathways, Science, 303, 1483, 10.1126/science.1094291 Chen, 2005, Nuclear translocations of β-catenin and TCF4 in gastric cancers correlate with lymph-node metastasis but probably not with CD44 expression, Hum Pathol, 36, 1294 Herman, 2003, Gene silencing in cancer in association with promoter hypermethylation, N Engl J Med, 349, 2042, 10.1056/NEJMra023075 Esteller, 2002, CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future, Oncogene, 21, 5427, 10.1038/sj.onc.1205600 Murai, 2005, Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer, Clin Cancer Res, 11, 1021 Akhtar, 2001, Promoter methylation regulates Helicobacter pylori–stimulated cyclooxygenase-2 expression in gastric epithelial cells, Cancer Res, 61, 2399 Sheu, 2003, Higher gastric cyclooxygenase-2 expression and precancerous change in Helicobacter pylori–infected relatives of gastric cancer patients, Clin Cancer Res, 9, 5245 Hur, 2003, Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas, Biochem Biophys Res Commun, 310, 844, 10.1016/j.bbrc.2003.09.095 Yu, 2003, Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma, Int J Oncol, 22, 1025 Song, 2001, Transcriptional silencing of cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells, Cancer Res, 61, 4628 Kikuchi, 2002, Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer, Int J Cancer, 97, 272, 10.1002/ijc.1612 Robert, 2003, DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells, Nat Genet, 33, 61, 10.1038/ng1068 Okano, 1998, Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases, Nat Genet, 19, 219, 10.1038/890 Hardie, 2005, p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations, Cancer Lett, 217, 221, 10.1016/j.canlet.2004.06.025 Sarbia, 2004, Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract, Int J Cancer, 111, 224, 10.1002/ijc.20212 Kim, 2003, Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability, J Pathol, 200, 23, 10.1002/path.1325 An, 2005, Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma, Clin Cancer Res, 11, 656 Waki, 2002, Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia, Am J Pathol, 161, 399, 10.1016/S0002-9440(10)64195-8